CBAK Energy Technology, Inc., together with its subsidiaries, manufacture, commercialization, and distribution of lithium ion high power rechargeable batteries in Mainland China, the United States, Europe, and internationally. The company operates in two segments, CBAK and Hitrans. Its lithium batteries are used in various applications, including electric vehicles, such as electric cars, electric buses, and hybrid electric cars and buses; light electric vehicles, such as electric bicycles, electric motors, electric tricycles, and smaller-sized electric cars; and electric tools, energy storage, uninterruptible power supply, and other high power applications, as well as cordless power tools. The company also develops and manufactures NCM precursor and cathode materials. The company was formerly known as China BAK Battery, Inc. and changed its name to CBAK Energy Technology, Inc. in January 2017. CBAK Energy Technology, Inc. is based in Dalian, China.

CBAK Energy Technology, Inc.

The following companies are expected to report earnings prior to market open on 03/17/2025. Visit our Earnings Calendar for a full list of expected earnings releases.
Qifu Technology, Inc (QFIN)is reporting for the quarter ending December 31, 2024. The technology services company's consensus earnings per share forecast from the 1 analyst that follows the stock is $1.68. This value represents a 75.00% increase compared to the same quarter last year. In the past year QFIN has met analyst expectations once and beat the expectations the other three quarters. Zacks Investment Research reports that the 2024 Price to Earnings ratio for QFIN is 7.00 vs. an industry ratio of 17.10.
Science Applications International Corporation (SAIC)is reporting for the quarter ending January 31, 2025. The information technology services company's consensus earnings per share forecast from the 6 analysts that follow the stock is $2.00. This value represents a 39.86% increase compared to the same quarter last year. Zacks Investment Research reports that the 2025 Price to Earnings ratio for SAIC is 12.15 vs. an industry ratio of 27.00.
Sonida Senior Living, Inc. (SNDA)is reporting for the quarter ending December 31, 2024. The medical services company's consensus earnings per share forecast from the 1 analyst that follows the stock is $-0.71. This value represents a 67.28% increase compared to the same quarter last year. In the past year SNDA Zacks Investment Research reports that the 2024 Price to Earnings ratio for SNDA is -19.35 vs. an industry ratio of 5.90.
Inspired Entertainment, Inc. (INSE)is reporting for the quarter ending December 31, 2024. The technology services company's consensus earnings per share forecast from the 1 analyst that follows the stock is $0.29. This value represents a 0.00% increase compared to the same quarter last year. Zacks Investment Research reports that the 2024 Price to Earnings ratio for INSE is 26.77 vs. an industry ratio of 17.10, implying that they will have a higher earnings growth than their competitors in the same industry.
Protalix BioTherapeutics, Inc. (PLX)is reporting for the quarter ending December 31, 2024. The consensus earnings per share forecast from the 2 analysts that follow the stock is $0.07. PLX reported earnings of $-0.07 per share for the same quarter a year ago; representing a a decrease of -200.00%.Townsquare Media, Inc. (TSQ)is reporting for the quarter ending December 31, 2024. The broadcast (radio/tv) company's consensus earnings per share forecast from the 2 analysts that follow the stock is $0.60. This value represents a 76.47% increase compared to the same quarter last year. Zacks Investment Research reports that the 2024 Price to Earnings ratio for TSQ is 7.11 vs. an industry ratio of -5.10, implying that they will have a higher earnings growth than their competitors in the same industry.
LanzaTech Global, Inc. (LNZA)is reporting for the quarter ending December 31, 2024. The technology services company's consensus earnings per share forecast from the 3 analysts that follow the stock is $-0.16. This value represents a 77.78% decrease compared to the same quarter last year. The last two quarters LNZA had negative earnings surprises; the latest report they missed by -123.08%. Zacks Investment Research reports that the 2024 Price to Earnings ratio for LNZA is -0.76 vs. an industry ratio of 17.10.
CBAK Energy Technology, Inc. (CBAT)is reporting for the quarter ending December 31, 2024. The electrical power company's consensus earnings per share forecast from the 1 analyst that follows the stock is $0.01. This value represents a 116.67% increase compared to the same quarter last year. CBAT missed the consensus earnings per share in the 3rd calendar quarter of 2024 by -100%. Zacks Investment Research reports that the 2024 Price to Earnings ratio for CBAT is 4.48 vs. an industry ratio of -7.60, implying that they will have a higher earnings growth than their competitors in the same industry.
NRX Pharmaceuticals, Inc. (NRXP)is reporting for the quarter ending December 31, 2024. The drug company's consensus earnings per share forecast from the 1 analyst that follows the stock is $-0.20. This value represents a 60.00% increase compared to the same quarter last year. In the past year NRXP and beat the expectations the other two quarters. Zacks Investment Research reports that the 2024 Price to Earnings ratio for NRXP is -1.18 vs. an industry ratio of -4.90, implying that they will have a higher earnings growth than their competitors in the same industry.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Pre-Market Earnings Report for March 17, 2025 : QFIN, SAIC, SNDA, INSE, PLX, TSQ, LNZA, CBAT, NRXP

The Invesco Golden Dragon China ETF is seeing unusually high volume in afternoon trading Monday, with over 1.1 million shares traded versus three month average volume of about 54,000. Shares of PGJ were up about 1.8% on the day.
Components of that ETF with the highest volume on Monday were NIO, trading up about 6.9% with over 166.1 million shares changing hands so far this session, and Iqiyi, up about 1.6% on volume of over 59.5 million shares. Cbak Energy Technology is the component faring the best Monday, higher by about 17.6% on the day, while Jin Medical International is lagging other components of the Invesco Golden Dragon China ETF, trading lower by about 4.6%.
VIDEO: Monday's ETF with Unusual Volume: PGJ
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Monday's ETF with Unusual Volume: PGJ

(RTTNews) - CBAK Energy Technology, Inc. (CBAT) posted a fourth quarter net loss attributable to shareholders of $4.8 million, compared to net loss of $10.7 million in the same period of 2022. Net loss attributable to shareholders after deducting the change in fair value of warrants was $4.8 million, compared to a net loss of $11.7 million, mainly due to the weaker performance of Hitrans, which was affected by the slowdown in the raw materials market. Net income from the battery business was $6.6 million, compared to a net loss of $6.4 million, a year ago.
Net revenues were $56.2 million, an increase of 3.2% compared to $54.5 million in the same period of 2022. The company said the increase was primarily attributable to an increase in revenue from the battery business, partially offset by a decrease in sales from Hitrans, which was affected by the slowdown in the raw materials market. Net revenues from sales of batteries were $36.8 million, an increase of 30.9% from $28.1 million in the same period of 2022.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

CBAK Energy Technology, Inc.

Price history

Shares 360

Investment risk — low

Investment potential — medium

Security parameters